Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF- [alpha] : A Possible Mechanism for Modulation of Atherogenesis.
| Publicado en: | BioMed Research International Vol. 2014; pp. 312647 - 312648 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103812033&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103812033 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 23146133 FT2T jtl: BioMed Research International issn: 23146133 maglogo: N pubinfo: dt: 2014 vid: 2014 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 103812033 2012493982 NLM24587984 PMC3920897 103812033 ppf: 312647 ppct: 1 formats: fmt: @attributes: type: P tig: atl: Infliximab Reverses Suppression of Cholesterol Efflux Proteins by TNF- [alpha] : A Possible Mechanism for Modulation of Atherogenesis. aug: au: Voloshyna, Iryna Seshadri, Sangeetha Anwar, Kamran Littlefield, Michael J Belilos, Elise Carsons, Steven E Reiss, Allison B affil: Winthrop Research Institute and Division of Rheumatology, Allergy and Immunology, Department of Medicine, Winthrop-University Hospital, 222 Station Plaza North, Suite 502, Mineola, NY 11501, USA. sug: subj: Carrier Proteins Metabolism Antibodies, Monoclonal Pharmacodynamics Atherosclerosis Metabolism Cholecalciferol Metabolism Cholesterol Metabolism Receptors, Cell Surface Metabolism Tumor Necrosis Factor Pharmacodynamics Carrier Proteins Biological Transport Drug Effects Cell Line Lipoproteins, LDL Metabolism Macrophages Drug Effects Macrophages Metabolism Monocytes Drug Effects Monocytes Metabolism Receptors, Cell Surface pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|